Arturo Sala

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Gene Expression

Genome Wide Identification

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Ylenia Cicirò, Denise Ragusa, Arturo Sala
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies. Scientific reports 14 (1) (2024)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters (2023)
Ylenia Cicirò, Denise Ragusa, Paloma Tejera Nevado, Rossano Lattanzio, Gianluca Sala, Tessa DesRochers, Melissa Millard, Mattias K Andersson, Göran Stenman, Arturo Sala
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma. FEBS letters 598 (2) (2023)
Denise Ragusa, Ylenia Cicirò, Concetta Federico, Salvatore Saccone, Francesca Bruno, Reza Saeedi, Cristina Sisu, Cristina Pina, Arturo Sala, Sabrina Tosi
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles. Oncogenesis 11 (1) (2022)
Ylenia Cicirò, Arturo Sala
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer. Oncogenesis 10 (2) (2021)
Alexia Tsakaneli, Victor Corasolla Carregari, Martina Morini, Alessandra Eva, Giuliana Cangemi, Olesya Chayka, Evgeny Makarov, Sandra Bibbò, Emily Capone, Gianluca Sala, Vincenzo De Laurenzi, Evon Poon, Louis Chesler, Luisa Pieroni, Martin R Larsen, Giuseppe Palmisano, Arturo Sala
MYC regulates metabolism through vesicular transfer of glycolytic kinases. Open biology 11 (12) (2021)